Intelligent Bio Solutions (INBS) Share-based Compensation (2024)
Intelligent Bio Solutions (INBS) recorded quarterly Share-based Compensation of $12000.0 in Q4 2024, down 94.06% quarter-over-quarter from $202045.0 in Q3 2024.
Intelligent Bio Solutions (INBS) Share-based Compensation (2024) Analysis & Trends
Intelligent Bio Solutions' Share-based Compensation history runs 1 years deep, the most recent figure standing at $12000.0 for Q4 2024.
- In Q4 2024, Share-based Compensation changed N/A year-over-year to $12000.0; the TTM figure through Mar 2025 stood at $214045.0 (changed N/A YoY), while the FY2023 annual figure was $260000.0, changed N/A from the prior year.
- Share-based Compensation was $12000.0 for Q4 2024 at Intelligent Bio Solutions, down from $202045.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $202045.0 in Q3 2024 to a low of $12000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 202,045.00 |
| Sep 30, 2024 | 202,045.00 |